Discovery Science
October 22, 2025
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
January 14, 2019
December 4, 2018
September 8, 2018
August 25, 2018
June 25, 2018
June 16, 2018
June 9, 2018
May 1, 2018
April 7, 2018
February 24, 2018
February 16, 2018
January 27, 2018
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community